Srinivasan, Meera http://orcid.org/0000-0002-3646-0952
Duncan, Joseph M.
Hibbert, Michael W. O.
Joffe, David
Mohammadieh, Anna M.
Cohen, Gary L.
Cistulli, Peter A.
Chan, Andrew S. L.
Funding for this research was provided by:
University of Sydney
Article History
Received: 14 October 2021
Revised: 23 December 2021
Accepted: 26 January 2022
First Online: 9 February 2022
Declarations
:
: The questionnaire and methodology for this study was approved by the Human Research Ethics Committee of the Northern Sydney Local Health District prior to commencement. Ethics approval RESP/18/162.
: Informed consent was obtained from all participants included in the study.
: Patients signed informed consent regarding publication of deidentified data.
: Financial interests: P.A Cistulli has an appointment to an endowed academic chair at the University of Sydney that was created from ResMed funding. He receives no personal fees and this relationship is managed by an Oversight Committee of the University. The remaining authors have no financial interests to declare.Non-financial interests: P. A. Cistulli has received research support from ResMed, SomnoMed, Zephyr Sleep Technologies, and Bayer. He is a consultant/adviser to Zephyr Sleep Technologies, Signifier Medical Technologies, SomnoMed and ResMed. The remaining authors have no non-financial interests to declare.